Related Articles
Neutrophil‑lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study
Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
Clinical value of serum tumor markers CA19‑9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma